BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11159191)

  • 21. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate.
    Ryan LM; Rachow JW; McCarty DJ
    J Rheumatol; 1991 May; 18(5):716-20. PubMed ID: 1650841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.
    Hessle L; Johnson KA; Anderson HC; Narisawa S; Sali A; Goding JW; Terkeltaub R; Millan JL
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9445-9. PubMed ID: 12082181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells.
    Solan JL; Deftos LJ; Goding JW; Terkeltaub RA
    J Bone Miner Res; 1996 Feb; 11(2):183-92. PubMed ID: 8822342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecto-nucleoside triphosphate pyrophosphohydrolase activity and calcium pyrophosphate dihydrate crystal deposition disease.
    Wortmann RL; Ryan LM; Karas B; McCarthy DJ
    Adv Exp Med Biol; 1986; 195 Pt A():153-6. PubMed ID: 3014830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance.
    Whitehead JP; Humphreys PJ; Dib K; Goding JW; O'Rahilly S
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):65-70. PubMed ID: 9302374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of inorganic pyrophosphate elaboration in cartilage by serum factors.
    Rosenthal AK; Cheung HS; Ryan LM
    Arch Biochem Biophys; 1989 Aug; 272(2):386-92. PubMed ID: 2546498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad3 plays an inhibitory role in phosphate-induced vascular smooth muscle cell calcification.
    Shimokado A; Sun Y; Nakanishi M; Sato F; Oikawa K; Akasaka T; Muragaki Y
    Exp Mol Pathol; 2014 Dec; 97(3):458-64. PubMed ID: 25303897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification.
    Narisawa S; Harmey D; Yadav MC; O'Neill WC; Hoylaerts MF; Millán JL
    J Bone Miner Res; 2007 Nov; 22(11):1700-10. PubMed ID: 17638573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF2 induced expression of the pyrophosphate generating enzyme, PC-1, is mediated by Runx2 and Msx2.
    Hatch NE; Franceschi RT
    J Musculoskelet Neuronal Interact; 2008; 8(4):318-20. PubMed ID: 19147956
    [No Abstract]   [Full Text] [Related]  

  • 30. Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.
    Rybalkin SD; Bornfeldt KE; Sonnenburg WK; Rybalkina IG; Kwak KS; Hanson K; Krebs EG; Beavo JA
    J Clin Invest; 1997 Nov; 100(10):2611-21. PubMed ID: 9366577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inorganic pyrophosphate generation and disposition in pathophysiology.
    Terkeltaub RA
    Am J Physiol Cell Physiol; 2001 Jul; 281(1):C1-C11. PubMed ID: 11401820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes.
    Rosenthal AK; Henry LA
    J Rheumatol; 1999 Feb; 26(2):395-401. PubMed ID: 9972975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium crystal-induced inflammation.
    Halverson PB; Derfus BA
    Curr Opin Rheumatol; 2001 May; 13(3):221-4. PubMed ID: 11333353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pyrophosphate and mineralization (TNSALP, PC-1, ANK)].
    Kaji H
    Clin Calcium; 2007 Oct; 17(10):1574-9. PubMed ID: 17906411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist.
    Johnson K; Farley D; Hu SI; Terkeltaub R
    Arthritis Rheum; 2003 May; 48(5):1302-14. PubMed ID: 12746903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrophosphate: a key inhibitor of mineralisation.
    Orriss IR; Arnett TR; Russell RG
    Curr Opin Pharmacol; 2016 Jun; 28():57-68. PubMed ID: 27061894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of matrix Gla protein and osteonectin mRNA by human aortic smooth muscle cells.
    Hao H; Hirota S; Ishibashi-Ueda H; Kushiro T; Kanmatsuse K; Yutani C
    Cardiovasc Pathol; 2004; 13(4):195-202. PubMed ID: 15210134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli.
    Boraldi F; Annovi G; Bartolomeo A; Quaglino D
    J Dermatol Sci; 2014 Apr; 74(1):72-80. PubMed ID: 24461675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal activity of nucleoside triphosphate pyrophosphatase in alkaline phosphatase-deficient fibroblasts from patients with infantile hypophosphatasia.
    Caswell AM; Whyte MP; Russell RG
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1237-41. PubMed ID: 3020080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR-associated craniosynostosis syndromes.
    Hatch NE
    Orthod Craniofac Res; 2007 May; 10(2):53-8. PubMed ID: 17552941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.